Monday, December 5, 2022 5pm to 7pm
About this Event
600 16th Street, San Francisco, California 94158
Please join us for this new series that highlights the symbiotic relationship between basic science research and clinical practice. Getting To Patients celebrates those who have successfully translated scientific discovery into direct patient benefit.
Our first speaker, Dr. Mark Walters, will share "Curative treatments for hereditary hemoglobin disorders," followed by a question and answer session with Tippi MacKenzie, Director, UCSF Broad Center and Sandy Feng, Vice-Chair for Research, Department of Surgery.
Mark Walters, MD
Program Director, Alpha Stem Cell Clinic
Program Director, Blood & Marrow Transplantation (BMT)
Program Director, Cord Blood Program
Medical Director, Jordan Family Center for BMT & Cellular Therapies Research
Dr. Walters is the Jordan Family Director of Bone Marrow Transplantation at UCSF Benioff Children’s Hospital Oakland. He has been the director of stem cell therapy and a division leader since 1999. He has devoted his research career to pursuing curative therapies for hemoglobin disorders with an overarching goal of expanding this treatment more broadly to affected individuals. With NIH and industry support, Dr. Walters has conducted a number of multicenter clinical trials for sickle cell disease and thalassemia. He is currently focused on initiating early-phase clinical trials to test novel genomic editing techniques in hematopoietic stem cells (HCT) from individuals affected by hemoglobin disorders, starting with a high-profile trial in sickle cell disease.
0 people are interested in this event
User Activity
No recent activity